QC
RCEL icon

Quadrature Capital’s Avita Medical RCEL Stock Holding History

Quadrature Capital’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$48.9K Buy
+11,829
New +$51K ﹤0.01% 1513

Other funds holding RCEL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TDC
Thompson Davis & Co Richmond, Virginia $167M AUM 33.45% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
RS
R Squared Central, Hong Kong $190M AUM 25.89% 1-Year Est. Return
AHL
Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return
NC
nVerses Capital Wellington, Florida $65M AUM
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
CAL
Capital Analysts LLC Fort Washington, Pennsylvania $4.34B AUM 17.55% 1-Year Est. Return

Quadrature Capital's RCEL Position: Q2 2026 in Review

Quadrature Capital opened a new position in Avita Medical (RCEL) in Q2 2026: 11,829 shares worth $48.9K. The stake represents ﹤0.01% of the portfolio and ranks #1513 among its holdings.

24 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • Quadrature Capital held 11,829 shares of Avita Medical worth $48.9K as of Q2 2026.
  • Avita Medical was a new Quadrature Capital position in Q2 2026.
  • Avita Medical made up ﹤0.01% of Quadrature Capital's portfolio in Q2 2026, its #1513 holding.
  • 24 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.